Although the diagnosis of LS requires the identification of a pathogenic germline MMR gene variant, LS is highly suspected in individuals with certain clinical features and whose tumors exhibit microsatellite instability (MSI) resulting from MMR deficiency (MMRd) (5). The gene discussed is MRC1; the disease is Leigh syndrome.